Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2005 1
2006 2
2007 1
2010 2
2011 4
2012 3
2013 1
2014 4
2015 4
2016 10
2017 8
2018 16
2019 14
2020 19
2021 19
2022 11
2023 12
2024 11
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Conti F, Serra C, Andreone P. Conti F, et al. Clin Gastroenterol Hepatol. 2021 Mar;19(3):619. doi: 10.1016/j.cgh.2020.04.072. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248100 No abstract available.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
Vitale A, Romano P, Cillo U; Writing Group for the HE.RC.O.LE.S Collaborative Group; Writing Group for the ITA.LI.CA Collaborative Group; HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups; Lauterio A, Sangiovanni A, Cabibbo G, Missale G, Marseglia M, Trevisani F, Foschi FG, Cipriani F, Famularo S, Marra F, Saitta C, Serenari M, Vidili G, Morisco F, Caturelli E, Mega A, Pelizzaro F, Nicolini D, Ardito F, Garancini M, Masotto A, Baroni GS, Azzaroli F, Giannini E, Perri P, Scarinci A, Fontana AP, Brunetto MR, Iaria M, Di Marco M, Nardone G, Dominioni T, Lai Q, Ferrari C, Rapaccini GL, Rodolfo S, Romano M, Conci S, Zoli M, Conticchio M, Zanello M, Zimmitti G, Fumagalli L, Troci A, Germani P, Gasbarrini A, La Barba G, De Angelis M, Patauner S, Molfino S, Zago M, Pinotti E, Frigo AC, Baiocchi GL, Frena A, Boccia L, Ercolani G, Tarchi P, Crespi M, Chiarelli M, Abu Hilal M, Cescon M, Memeo R, Ruzzenente A, Zanus G, Griseri G, Rossi M, Maestri M, Della Valle R, Ferrero A, Grazi GL, Romano F, Giuliante F, Vivarelli M, Jovine E, Torzilli G, Aldrighetti L, De Carlis L. Vitale A, et al. JAMA Surg. 2024 Aug 1;159(8):881-889. doi: 10.1001/jamasurg.2024.1184. JAMA Surg. 2024. PMID: 38771633 Free PMC article.
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab.
Rimini M, Montes M, Amadeo E, Vitiello F, Kudo M, Tada T, Suda G, Shimose S, Lonardi S, Finkelmeier F, Salani F, Antonuzzo L, Marra F, Iavarone M, Cabibbo G, Foschi FG, Silletta M, Sacco R, Rapposelli IG, Scartozzi M, Nicoletta P, Aldrighetti L, Persano M, Camera S, Rossari F, Foti S, Kumada T, Hiraoka A, Iwamoto H, Rizzato MD, Himmelsbach V, Masi G, Corradi M, Celsa C, Fabio C, Frassineti GL, Cascinu S, Casadei-Gardini A, Presa J. Rimini M, et al. Sci Rep. 2024 Aug 30;14(1):20200. doi: 10.1038/s41598-024-70928-z. Sci Rep. 2024. PMID: 39215078 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Pasta A, Pieri G, Plaz Torres MC, Missale G, Foschi FG, Piscaglia F, Boninsegna S, Mega A, Cazzagon N, Pelizzaro F, Viganò M, Trevisani F, Bucci L, Azzaroli F, Brunetto MR, Campani C, Celsa C, Ghittoni G, Magalotti D, Martini A, Morisco F, Nardone G, Ponziani FR, Sacco R, Sacerdoti D, Saitta C, Sangiovanni A, Lani L, Svegliati-Baroni G, Vidili G, Vitale A, Giannini EG; Italian Liver Cancer (ITA.LI.CA) Group. Pasta A, et al. Dig Dis Sci. 2025 Aug;70(8):2865-2872. doi: 10.1007/s10620-025-09064-1. Epub 2025 May 3. Dig Dis Sci. 2025. PMID: 40317369 Free PMC article.
Outcome of hepatic resection for HCC in ideal and non-ideal candidates.
Lani L, Bucci L, Santi V, Stefanini B, Stefanini B, Sangiovanni A, Grasselli S, Ghittoni G, Saitta C, Morisco F, Cabibbo G, Marra F, Vidili G, Brunetto MR, Foschi FG, Di Marco M, Svegliati-Baroni G, Pelizzaro F, Azzaroli F, Ponziani FR, Martini A, Sacerdoti D, Mega A, Boninsegna S, Giannini EG, Magalotti D, Sacco R, Nardone G, Caraceni P, Vitale A, Trevisani F; and the Italian Liver Cancer group. Lani L, et al. Hepatol Commun. 2025 Jul 29;9(8):e0772. doi: 10.1097/HC9.0000000000000772. eCollection 2025 Aug 1. Hepatol Commun. 2025. PMID: 40719550 Free PMC article.
Vessel health and preservation: An integrative review.
Fiorini J, Venturini G, Conti F, Funaro E, Caruso R, Kangasniemi M, Sili A. Fiorini J, et al. J Clin Nurs. 2019 Apr;28(7-8):1039-1049. doi: 10.1111/jocn.14707. Epub 2018 Nov 14. J Clin Nurs. 2019. PMID: 30358005 Review.
133 results